Company Information & Drug Savings for Sumitomo Pharma America, Inc. Medications

Sumitomo Pharma America is the US subsidiary of Japanese pharmaceutical company Sumitomo Pharma. The company focuses on CNS disorders including schizophrenia, depression, and Parkinson’s disease through its Sunovion division. Key products include Latuda (lurasidone) for schizophrenia and bipolar depression. Sumitomo’s neuroscience research advances psychiatric and neurological treatments.

Sumitomo Pharma America, Inc.

How to Contact Sumitomo Pharma America, Inc.

Browse Medications Manufactured by Sumitomo Pharma America, Inc.

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch